Research programme: stroke therapy - BioTime/University of California Los Angeles
Latest Information Update: 16 Jul 2016
At a glance
- Originator BioTime; University of California at Los Angeles
- Class Growth factors; Nerve growth factors
- Mechanism of Action Brain-derived neurotrophic factor expression stimulants; Neuron stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Stroke